TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11779390

Group type: EXPERIMENTAL
Intervention: zanamivir (Relenza)
Number of subjects: 0
Study: 9533558

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 supplementation
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 7882462

Group type: EXPERIMENTAL
Intervention: Vinfosiltine (S12363) at 0.3 mg/m2 given weekly
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Vinfosiltine (S12363) at 0.6 mg/m2 given every 2 weeks
Number of subjects: 22
Study: 2204548

Group type: EXPERIMENTAL
Intervention: Standard stripping of the long saphenous vein
Number of subjects: 42

Group type: COMPARATOR
Intervention: High ligation
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups (standard stripping and high ligation)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Preserved saphenous veins
Number of subjects: 42
Study: 391623

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dipyridamole
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of acetylsalicylic acid and dipyridamole
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 20
Study: 31912860

Group type: EXPERIMENTAL
Intervention: Lupin-enriched foods
Number of subjects: 22
Study: 30819510

Group type: EXPERIMENTAL
Intervention: Nemonoxacin 500 mg single dose
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nemonoxacin
Number of subjects: 20
Study: 28693563

Group type: EXPERIMENTAL
Intervention: Traditional acupuncture (group A)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Sham acupuncture (group E)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Shallow‐puncture (group B)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Non‐acupoint acupuncture (group C)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Non‐acupoint shallow‐puncture (group D)
Number of subjects: 175
Study: 25708763

Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Cold forceps polypectomy (CFP)
Number of subjects: 139
Study: 23910795

Group type: EXPERIMENTAL
Intervention: AT Basel mutation (p.Pro73Leu)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: AT activity assays
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: No mutation detected
Number of subjects: 104
Study: 20093975

Group type: EXPERIMENTAL
Intervention: Heart Rate Group (HRG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Perceptive Group (PG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 27
Study: 18445072

Group type: EXPERIMENTAL
Intervention: Informed consent reported in trial protocols
Number of subjects: 312

Group type: COMPARATOR
Intervention: Active controls
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Post-trial provisions
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Surrogate outcomes
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Patient-important outcomes
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Outcomes in low income countries
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Pharmaceutical company involvement
Number of subjects: 312
Study: 17276855

Group type: EXPERIMENTAL
Intervention: Group 1 (intraosseous screw without acrylic plate)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group 2 (intraosseous screw with acrylic plate resembling Nance button)
Number of subjects: 40
Study: 15483465

Group type: EXPERIMENTAL
Intervention: Indinavir (IDV)/Ritonavir (RTV) at 800/200 mg (arm A)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Indinavir (IDV)/Ritonavir (RTV) at 400/400 mg (arm B)
Number of subjects: 44
Study: 11237912

Group type: EXPERIMENTAL
Intervention: 2-year diabetes educational intervention arm (mailed packets and newsletters focused on vision care)
Number of subjects: 2308

Group type: COMPARATOR
Intervention: Control nonintervention arm
Number of subjects: 2308
Study: 11600092

Group type: EXPERIMENTAL
Intervention: Albendazole 400 mg (single annual dose)
Number of subjects: 0
Study: 9315596

Group type: EXPERIMENTAL
Intervention: Marine oil plus simvastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Marine oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simvastatin
Number of subjects: 0
Study: 8101554

Group type: EXPERIMENTAL
Intervention: Balloon dilation of left internal thoracic arteries (LITAs)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Balloon dilation of right internal thoracic arteries (RITAs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (non-dilated ITAs)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Papaverine injection
Number of subjects: 25
Study: 3550455

Group type: EXPERIMENTAL
Intervention: Nifedipine (0.75-1 mg/kg/day for the first 6 months and 1.5-2 mg/kg/day for the next 12 months)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Nifedipine and Placebo
Number of subjects: 105
Study: 2515880

Group type: EXPERIMENTAL
Intervention: Zidovudine therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined measurements of S‐TK and neutrophil counts
Number of subjects: 16
Study: 31107775

Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral intervention (five monthly in-home sessions and telephone consultations)
Number of subjects: 112

Group type: COMPARATOR
Intervention: General conversations with nurse interventionists (control group)
Number of subjects: 112
Study: 28734822

Group type: EXPERIMENTAL
Intervention: Icotinib 125 mg orally (three times per day)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Whole-brain irradiation (WBI) 30 Gy in ten fractions of 3 Gy plus chemotherapy for 4-6 cycles
Number of subjects: 176
Study: 26370656

Group type: EXPERIMENTAL
Intervention: PGE500 (500 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PGE1500 (1500 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 23351824

Group type: EXPERIMENTAL
Intervention: n-3 PUFA 1 g/daily
Number of subjects: 1203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1203
Study: 21283919

Group type: EXPERIMENTAL
Intervention: Cetaphil UVA/UVB Defense SPF 50 sunscreen exposed to natural sunlight (4 doses ranging from 2–6 MED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cetaphil UVA/UVB Defense SPF 50 sunscreen unexposed to sunlight
Number of subjects: 0

Group type: COMPARATOR
Intervention: UVB-SPF 15 control sunscreen
Number of subjects: 0
Study: 19453893

Group type: EXPERIMENTAL
Intervention: Tadalafil 2.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tadalafil 20 mg (as historical control)
Number of subjects: 0
Study: 17966178

Group type: EXPERIMENTAL
Intervention: Intense pulsed light (IPL, 600-850 nm)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of IPL (580-980 nm) and bipolar radiofrequency (RF) energies
Number of subjects: 22

Group type: COMPARATOR
Intervention: Blue light (417 nm)
Number of subjects: 22
Study: 15166572

Group type: EXPERIMENTAL
Intervention: Amitriptyline 20 mM
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bupivacaine 4 mM
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 11322868

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0
Study: 9831637

Group type: EXPERIMENTAL
Intervention: Normocholesterolemic patients with primary biliary cirrhosis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic patients with primary biliary cirrhosis
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Patients with primary biliary cirrhosis
Number of subjects: 25
Study: 7906386

Group type: EXPERIMENTAL
Intervention: 500 mg of zidovudine per day
Number of subjects: 1338

Group type: EXPERIMENTAL
Intervention: 1500 mg of zidovudine per day
Number of subjects: 1338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1338
Study: 2780003

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester (0.5 microgram)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester (0.25 microgram)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha‐1‐isopropyl ester and Vehicle
Number of subjects: 24
Study: 961922

Group type: EXPERIMENTAL
Intervention: Marijuana
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31608939

Group type: EXPERIMENTAL
Intervention: Robotic McKeown esophagectomy (RME)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Thoraco-laparoscopic McKeown esophagectomy (TLME)
Number of subjects: 652
Study: 31406013

Group type: EXPERIMENTAL
Intervention: Team-based outpatient early palliative care (TO-EPC)
Number of subjects: 0
Study: 27746408

Group type: EXPERIMENTAL
Intervention: Insulin degludec (IDeg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Insulin glargine (IGlar)
Number of subjects: 18
Study: 25803346

Group type: EXPERIMENTAL
Intervention: Balloon-expandable stent plus medical therapy (stent group; n=59)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Medical therapy alone (medical group; n=53)
Number of subjects: 112
Study: 23610518

Group type: EXPERIMENTAL
Intervention: Younger men
Number of subjects: 12

Group type: COMPARATOR
Intervention: Older men
Number of subjects: 12
Study: 21334564

Group type: EXPERIMENTAL
Intervention: New cognitive‐behaviorally based parenting intervention (10 sessions, group format)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 74
Study: 19812684

Group type: EXPERIMENTAL
Intervention: Chronic bronchitis
Number of subjects: 1934

Group type: EXPERIMENTAL
Intervention: Emphysema
Number of subjects: 1934

Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 1934

Group type: EXPERIMENTAL
Intervention: Asthma
Number of subjects: 1934
Study: 17223985

Group type: EXPERIMENTAL
Intervention: Tibolone at a dose of 2.5‐7.5 mg/day
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 8
Study: 15080514

Group type: EXPERIMENTAL
Intervention: 5-Hydroxy Indole Acetic Acid (5-HIAA) measurement in spot urine
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (patients prepared for hernia repair)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5-HIAA measurement in patients with gangrenous appendicitis
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 5-HIAA measurement in patients without histopathological gangrenous changes
Number of subjects: 26
Study: 11808764

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) applied annually
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) with soft carious tissue removal applied annually
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: NaF varnish (22,600 ppm F) applied every three months
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: NaF varnish (22,600 ppm F) with soft carious tissue removal applied every three months
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 375
Study: 9555445

Group type: EXPERIMENTAL
Intervention: Self-applied breathing and guided imagery relaxation techniques, separately and in combination, and a reinforcement tool
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 20
Study: 7989469

Group type: EXPERIMENTAL
Intervention: Black subjects
Number of subjects: 12

Group type: COMPARATOR
Intervention: White subjects
Number of subjects: 12
Study: 3142243

Group type: EXPERIMENTAL
Intervention: Streptokinase (n = 41)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo (n = 25)
Number of subjects: 66
Study: 31268131

Group type: EXPERIMENTAL
Intervention: Time-restricted feeding (TRF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TRF plus 3 g/d HMB (TRFHMB)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control diet (CD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All groups (TRF, TRFHMB, CD)
Number of subjects: 40
Study: 28830632

Group type: EXPERIMENTAL
Intervention: Intervention from two randomized controlled trials
Number of subjects: 0
Study: 27036112

Group type: EXPERIMENTAL
Intervention: Brief advisory session plus measuring exhaled CO
Number of subjects: 112

Group type: COMPARATOR
Intervention: Brief advisory session
Number of subjects: 112
Study: 25449504

Group type: EXPERIMENTAL
Intervention: 4.5 mg adenosine (ADO)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 201
Study: 23575051

Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (250 mg twice a day for three months)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Routine topical therapies
Number of subjects: 260
Study: 19531111

Group type: EXPERIMENTAL
Intervention: Intensive interpersonal psychotherapy for depressed adolescents with suicidal risk (IPT‐A‐IN)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 73
Study: 17311685

Group type: EXPERIMENTAL
Intervention: Educational intervention using postcards and posters on depression and its treatment
Number of subjects: 3313

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 3313
Study: 14756643

Group type: EXPERIMENTAL
Intervention: 595-nm PDL at fluence 15 J/cm2 (1.5 ms)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 595-nm PDL at fluence 15 J/cm2 (10 ms)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 532-nm Nd:YAG laser at 2 ms, 7 J/cm2
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 532-nm Nd:YAG laser at 10 ms, 16 J/cm2
Number of subjects: 22

Group type: COMPARATOR
Intervention: 585-nm 0.45-ms PDL (control area)
Number of subjects: 22
Study: 11453905

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (Betamethasone valerate or common base)
Number of subjects: 26
Study: 9543445

Group type: EXPERIMENTAL
Intervention: gp160 in alum over a 2‐year period in combination with placebo (n = 32)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: gp160 in alum over a 2‐year period in combination with zidovudine (n = 34)
Number of subjects: 99

Group type: COMPARATOR
Intervention: alum over a 2‐year period in combination with zidovudine (n = 33)
Number of subjects: 99
Study: 8066108

Group type: EXPERIMENTAL
Intervention: Ultrasound/Ultraviolet-C (US/UVC) treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laser treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nursing care alone
Number of subjects: 20
Study: 3143277

Group type: EXPERIMENTAL
Intervention: Urapidil (60 mg orally thrice a day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30576539

Group type: EXPERIMENTAL
Intervention: Gonadotrophins
Number of subjects: 666

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: IUI
Number of subjects: 666

Group type: COMPARATOR
Intervention: Intercourse
Number of subjects: 666
Study: 28438185

Group type: EXPERIMENTAL
Intervention: Conventional moxibustion (n=69)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Smoke-free moxibustion (n=69)
Number of subjects: 138
Study: 25328886

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training for 4 months
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training
Number of subjects: 21
Study: 23529632

Group type: EXPERIMENTAL
Intervention: Minimally invasive technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional open surgery using K wires
Number of subjects: 40
Study: 20528706

Group type: EXPERIMENTAL
Intervention: Guided self-help (internet-based)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stepped care model (including watchful waiting, guided self-help, brief psychotherapy, longer-term psychotherapy, and antidepressant medication)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Watchful waiting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief face-to-face psychotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer-term face-to-face psychotherapy and antidepressant medication
Number of subjects: 0
Study: 17663986

Group type: EXPERIMENTAL
Intervention: Spatial task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verbal shadowing task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Incidental learning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Room size larger than used by Hermer‐Vazquez et al.
Number of subjects: 0
Study: 16160875

Group type: EXPERIMENTAL
Intervention: Alcohol (1 ml/kg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 12648863

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (4.0 g loading dose over 30 min, followed by 1-2 g/hour continuous infusion for up to 21 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate
Number of subjects: 0
Study: 10808727

Group type: EXPERIMENTAL
Intervention: Evidence-based medicine (EBM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potential adverse influences of EBM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Potential misuse of statistical methods
Number of subjects: 0
Study: 8698279

Group type: EXPERIMENTAL
Intervention: Tea drinking (6 mugs of tea daily for 4 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo (matched intakes of milk, sugar, water, and caffeine for 4 weeks)
Number of subjects: 65
Study: 8381935

Group type: EXPERIMENTAL
Intervention: High-permeability modified cellulose membrane (Hemophan-HP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poly(ethylene-co-vinyl alcohol) (EVAL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poly(acrylonitrile-co-sodium methallyl sulphonate) (AN69)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cuprophan
Number of subjects: 0
Study: 3529153

Group type: EXPERIMENTAL
Intervention: Verapamil (calcium antagonist) at doses of 320-480 mg/day
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 29661674

Group type: EXPERIMENTAL
Intervention: Deltoid ligament repair with suture anchor
Number of subjects: 59

Group type: COMPARATOR
Intervention: Syndesmosis screw fixation
Number of subjects: 59
Study: 25370731

Group type: EXPERIMENTAL
Intervention: Azathioprine (AZA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 0
Study: 22687558

Group type: EXPERIMENTAL
Intervention: Active stimulation (LH anodal/RH cathodal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active stimulation (RH anodal/LH Cathodal)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 20458545

Group type: EXPERIMENTAL
Intervention: Weight loss program (Phase 1)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Weight maintenance approaches (Phase 2)
Number of subjects: 87
Study: 17493509

Group type: EXPERIMENTAL
Intervention: M. charantia capsules (two capsules three times a day after meals for 3 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (two capsules three times a day after meals for 3 months)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: M. charantia capsules
Number of subjects: 40
Study: 16173223

Group type: EXPERIMENTAL
Intervention: Midazolam 0.5 mg/kg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Diazepam 0.3 mg/kg
Number of subjects: 13
Study: 12132548

Group type: EXPERIMENTAL
Intervention: Learner-centred educational project in end-of-life care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 10792471

Group type: EXPERIMENTAL
Intervention: Koate(R)‐DVI (heat‐treated preparation)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Koate(R)‐HP (unheated preparation)
Number of subjects: 54
Study: 8543748

Group type: EXPERIMENTAL
Intervention: 15 mg of furosemide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 30 mg of furosemide
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2720135

Group type: EXPERIMENTAL
Intervention: 50 mg nitrofurantoin tablet
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: USP Apparatus 1 at 100 rev min‐1 with pH 7.2 fluid at 30 min
Number of subjects: 14
Study: 794000

Group type: EXPERIMENTAL
Intervention: Indoprofen 600 mg daily for 7 days
Number of subjects: 39

Group type: COMPARATOR
Intervention: Ibuprofen 900 mg daily for 7 days
Number of subjects: 39
Study: 31474439

Group type: EXPERIMENTAL
Intervention: Pegcetacoplan monthly
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pegcetacoplan every other month (EOM)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pegcetacoplan EOM
Number of subjects: 246

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 246
Study: 31624047

Group type: EXPERIMENTAL
Intervention: CVD treatment (cyclophosphamide, bortezomib, and dexamethasone)
Number of subjects: 583

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 583
Study: 29239658

Group type: EXPERIMENTAL
Intervention: 25 sessions of adaptive, process-based working memory training
Number of subjects: 142

Group type: COMPARATOR
Intervention: Active, adaptive visual search control group
Number of subjects: 142
Study: 24993395

Group type: EXPERIMENTAL
Intervention: Cranberry capsules (72 mg proanthocyanidins)
Number of subjects: 41
Study: 22869158

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with radial firing tips (RFT) - RFT2 (140 μs, 37.5 mJ, 20 Hz) and RFT3 (140 μs, 62.5 mJ, 20 Hz) used in the second appointment, moving at 2 mm s(‐1) from apical to coronal.
Number of subjects: 29

Group type: COMPARATOR
Intervention: 3% sodium hypochlorite and calcium hydroxide as inter-appointment dressing.
Number of subjects: 29
Study: 21732195

Group type: EXPERIMENTAL
Intervention: Patient+physician intensive group
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Physician communication skills training and patient coaching by community health workers
Number of subjects: 279

Group type: COMPARATOR
Intervention: Patient+physician minimal group
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Physician intensive/patient minimal group
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Patient intensive/physician minimal group
Number of subjects: 279